Emerging from the UK, retatrutide, a new molecule, is generating considerable buzz within the medical community regarding its promise for physique regulation. This dual GIP and GLP-1 agent agonist seems to deliver a significant benefit over established therapies, showing positive results in initial clinical studies . Researchers think its particula